Aezs stock price target islzczm

Aezs stock price target

16.03.2021

Drews39095

Feb 08, 2020 · Æterna Zentaris Inc. (TSX: AEZ, NASDAQ: AEZS) is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer.The Company's innovative approach of "personalized medicine" means tailoring treatments to a AEterna Zentaris Inc. Stock Price (AEZS) | Barron's View today's stock price, news and analysis for AEterna Zentaris Inc. (AEZS). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and Aeterna Zentaris Inc, AEZS:TOR summary - FT.com Latest Aeterna Zentaris Inc (AEZS:TOR) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Is It Right Time to Be Bullish on Aeterna Zentaris Inc ...

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology.

Nov 08, 2019 · Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Aeterna Zentaris Inc. Common Stock (AEZS) Stock Quotes ... Mar 26, 2019 · Aeterna Zentaris Inc. Common Stock (AEZS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

The stock was given Buy rating by Maxim Group in its report released on January 17, 2017, the day when the price target on the stock was placed at 10. H.C. Wainwright was of a view that AEZS is Buy in its latest report on December 02, 2015. H.C. Wainwright thinks that AEZS is worth Buy rating.

AEZS:NASDAQ CM Stock Quote - Aeterna Zentaris Inc ... Stock analysis for Aeterna Zentaris Inc (AEZS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AEZS - Aeterna Zentaris Inc Stock quote - CNNMoney.com

1 day ago On average, stock market experts give AEZS an Buy rating. The average 12- month price forecast for this stock is $0.65, with the high estimate

The stock was given Buy rating by Maxim Group in its report released on January 17, 2017, the day when the price target on the stock was placed at 10. H.C. Wainwright was of a view that AEZS is Buy in its latest report on December 02, 2015. H.C. Wainwright thinks that AEZS is worth Buy rating. Canaccord Lowers Price Target on AEterna Zentaris Inc ... Nov 11, 2016 · As such, the analyst reiterates a Speculative Buy rating on shares of AEZS while pulling back on the price target from $9.00 to $7.50, which represents just under a 154% increase from where the AEZS Stock News - Fidelity Apr 01, 2020 · Aeterna Zentaris Inc. (AEZS), a specialty biopharmaceutical company engaged in commercializing novel pharmaceutical therapies, today announced that it has received notice from The Nasdaq Stock Market LLC that the Company has regained compliance with Nasdaq s minimum bid price for continued listing on the Nasdaq Capital Market set forth in Aeterna Zentaris Inc, AEZS:NAQ forecasts - FT.com

Jul 19, 2017 · Today, Maxim Group raised its price target on AEterna Zentaris (NASDAQ:AEZS) to $4.00 per share. There are 3 buy ratings on the stock.

AEZS Price Target | Aeterna Zentaris Stock Forecast & Ratings